1395 related articles for article (PubMed ID: 17560755)
21. Pain and symptom control in paediatric palliative care.
Stevens MM; Dalla Pozza L; Cavalletto B; Cooper MG; Kilham HA
Cancer Surv; 1994; 21():211-31. PubMed ID: 8564995
[TBL] [Abstract][Full Text] [Related]
22. Opioid rotation from morphine to fentanyl in delirious cancer patients: an open-label trial.
Morita T; Takigawa C; Onishi H; Tajima T; Tani K; Matsubara T; Miyoshi I; Ikenaga M; Akechi T; Uchitomi Y;
J Pain Symptom Manage; 2005 Jul; 30(1):96-103. PubMed ID: 16043013
[TBL] [Abstract][Full Text] [Related]
23. Continuous intrathecal morphine infusion in patients with vertebral fractures due to osteoporosis.
Shaladi A; Saltari MR; Piva B; Crestani F; Tartari S; Pinato P; Micheletto G; Dall'Ara R
Clin J Pain; 2007; 23(6):511-7. PubMed ID: 17575491
[TBL] [Abstract][Full Text] [Related]
24. Safety and effectiveness of intravenous morphine for episodic breakthrough pain in patients receiving transdermal buprenorphine.
Mercadante S; Villari P; Ferrera P; Porzio G; Aielli F; Verna L; Casuccio A
J Pain Symptom Manage; 2006 Aug; 32(2):175-9. PubMed ID: 16877185
[TBL] [Abstract][Full Text] [Related]
25. Opioid switch in palliative care, opioid choice by clinical need and opioid availability.
Müller-Busch HC; Lindena G; Tietze K; Woskanjan S
Eur J Pain; 2005 Oct; 9(5):571-9. PubMed ID: 16139186
[TBL] [Abstract][Full Text] [Related]
26. Safety and effectiveness of intravenous morphine for episodic (breakthrough) pain using a fixed ratio with the oral daily morphine dose.
Mercadante S; Villari P; Ferrera P; Bianchi M; Casuccio A
J Pain Symptom Manage; 2004 Apr; 27(4):352-9. PubMed ID: 15050663
[TBL] [Abstract][Full Text] [Related]
27. [Effects of sustained release morphine hydrochloride tablets in management of cancer pain: a survey of 567 patients].
Yu SY; Qiu H; Ma ZS; Chen J; Zhang Y; Chen LZ; Wang DL; Ma ZY
Zhonghua Yi Xue Za Zhi; 2004 Mar; 84(6):450-5. PubMed ID: 15061959
[TBL] [Abstract][Full Text] [Related]
28. Opioids in the management of chronic non-cancer pain: an update of American Society of the Interventional Pain Physicians' (ASIPP) Guidelines.
Trescot AM; Helm S; Hansen H; Benyamin R; Glaser SE; Adlaka R; Patel S; Manchikanti L
Pain Physician; 2008 Mar; 11(2 Suppl):S5-S62. PubMed ID: 18443640
[TBL] [Abstract][Full Text] [Related]
29. Use of sustained release oral morphine as a bridge in withdrawal of morphine in patients on high doses of oral immediate release morphine for cancer pain.
Ahmed A; Khurana H; Gogia V; Mishra S; Bhatnagar S
Am J Hosp Palliat Care; 2010 Sep; 27(6):413-5. PubMed ID: 20220200
[TBL] [Abstract][Full Text] [Related]
30. Opioid switching from transdermal fentanyl to oral methadone in patients with cancer pain.
Benítez-Rosario MA; Feria M; Salinas-Martín A; Martínez-Castillo LP; Martín-Ortega JJ
Cancer; 2004 Dec; 101(12):2866-73. PubMed ID: 15529307
[TBL] [Abstract][Full Text] [Related]
31. Toward freedom from cancer pain in Japan.
Otsuka K; Yasuhara H
J Pain Palliat Care Pharmacother; 2007; 21(3):37-42. PubMed ID: 18032354
[TBL] [Abstract][Full Text] [Related]
32. [Management of intractable cancer pain: from intrathecal morphine to cell allograft].
Lazorthes Y; Sallerin B; Verdie JC; Sol JC; Duplan H; Tkaczuk J; Tafani M; Bastide R; Bes JC
Neurochirurgie; 2000 Nov; 46(5):454-65. PubMed ID: 11084478
[TBL] [Abstract][Full Text] [Related]
33. [Morphine dose and side effects: a comparison of older and younger patients with tumor pain].
Loick G; Radbruch L; Sabatowski R; Siessegger M; Grond S; Lehmann KA
Dtsch Med Wochenschr; 2000 Oct; 125(41):1216-21. PubMed ID: 11076259
[TBL] [Abstract][Full Text] [Related]
34. Oral oxycodone: new preparation. No better than oral morphine.
Prescrire Int; 2003 Jun; 12(65):83-4. PubMed ID: 12825566
[TBL] [Abstract][Full Text] [Related]
35. Paediatric cancer pain management using the WHO analgesic ladder--results of a prospective analysis from 2265 treatment days during a quality improvement study.
Zernikow B; Smale H; Michel E; Hasan C; Jorch N; Andler W
Eur J Pain; 2006 Oct; 10(7):587-95. PubMed ID: 16243549
[TBL] [Abstract][Full Text] [Related]
36. Normal-release oral morphine starting dose in cancer patients with pain.
Ripamonti CI; Campa T; Fagnoni E; Brunelli C; Luzzani M; Maltoni M; De Conno F;
Clin J Pain; 2009 Jun; 25(5):386-90. PubMed ID: 19454871
[TBL] [Abstract][Full Text] [Related]
37. Long-acting morphine for pain control in paediatric oncology.
Zernikow B; Lindena G
Med Pediatr Oncol; 2001 Apr; 36(4):451-8. PubMed ID: 11260568
[TBL] [Abstract][Full Text] [Related]
38. Drug-related side effects of long-term intrathecal morphine therapy.
Ruan X
Pain Physician; 2007 Mar; 10(2):357-66. PubMed ID: 17387357
[TBL] [Abstract][Full Text] [Related]
39. [Standards, Options and Recommendations (SOR): clinical practice guidelines for diagnosis, treatment and follow-up of cutaneous melanoma. Fédération Nationale des Centres de Lutte Contre le Cancer].
Négrier S; Fervers B; Bailly C; Beckendorf V; Cupissol D; Doré JF; Dorval T; Garbay JR; Vilmer C
Bull Cancer; 2000 Feb; 87(2):173-82. PubMed ID: 10705288
[TBL] [Abstract][Full Text] [Related]
40. The MERITO Study: a multicentre trial of the analgesic effect and tolerability of normal-release oral morphine during 'titration phase' in patients with cancer pain.
De Conno F; Ripamonti C; Fagnoni E; Brunelli C; Luzzani M; Maltoni M; Arcuri E; Bertetto O;
Palliat Med; 2008 Apr; 22(3):214-21. PubMed ID: 18477715
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
